IBKS No3 SPAC

KQ:225430 Korea Asset Management
Market Cap
$7.77 Million
₩11.38 Billion KRW
Market Cap Rank
#31474 Global
#2081 in Korea
Share Price
₩408.00
Change (1 day)
+1.75%
52-Week Range
₩340.00 - ₩685.00
All Time High
₩4900.00
About

KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, an… Read more

IBKS No3 SPAC (225430) - Total Assets

Latest total assets as of September 2025: ₩47.78 Billion KRW

Based on the latest financial reports, IBKS No3 SPAC (225430) holds total assets worth ₩47.78 Billion KRW as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

IBKS No3 SPAC - Total Assets Trend (2015–2024)

This chart illustrates how IBKS No3 SPAC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

IBKS No3 SPAC - Asset Composition Analysis

Current Asset Composition (December 2024)

IBKS No3 SPAC's total assets of ₩47.78 Billion consist of 9.6% current assets and 90.4% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩221.05 Million 0.5%
Accounts Receivable ₩1.24 Billion 2.5%
Inventory ₩2.42 Billion 5.0%
Property, Plant & Equipment ₩21.10 Billion 43.1%
Intangible Assets ₩14.24 Million 0.0%
Goodwill ₩0.00 0.0%

Asset Composition Trend (2015–2024)

This chart illustrates how IBKS No3 SPAC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: IBKS No3 SPAC's current assets represent 9.6% of total assets in 2024, a decrease from 100.0% in 2015.
  • Cash Position: Cash and equivalents constituted 0.5% of total assets in 2024, down from 3.4% in 2015.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
  • Asset Diversification: The largest asset category is property, plant & equipment at 43.1% of total assets.

IBKS No3 SPAC Competitors by Total Assets

Key competitors of IBKS No3 SPAC based on total assets are shown below.

Company Country Total Assets
Bexil Cp
PINK:BXLC
USA $29.44 Million
Norte Grande
SN:NORTEGRAN
Chile CL$2.91 Billion
BlackRock Capital Allocation Trust
NYSE:BCAT
USA $1.87 Billion
Big Tech 50 R&D-Limited Partnership
TA:BIGT
Israel ILA14.08 Million
Zhuhai Huajin Capital Co Ltd
SHE:000532
China CN¥2.38 Billion
Shaanxi International Trust Co Ltd
SHE:000563
China CN¥29.45 Billion
Sichuan Shuangma Cement Co Ltd
SHE:000935
China CN¥9.30 Billion
Sk Securities
KO:001510
Korea ₩7.28 Trillion

IBKS No3 SPAC - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.00 - 0.53

Lower asset utilization - IBKS No3 SPAC generates 0.30x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -37.67% - 0.94%

Negative ROA - IBKS No3 SPAC is currently not profitable relative to its asset base.

IBKS No3 SPAC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.38 0.63 3.90
Quick Ratio 0.19 0.36 2.89
Cash Ratio 0.00 0.00 0.00
Working Capital ₩-7.07 Billion ₩ -3.30 Billion ₩ 9.00 Billion

IBKS No3 SPAC - Advanced Valuation Insights

This section examines the relationship between IBKS No3 SPAC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.33
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -3.1%
Total Assets ₩48.97 Billion
Market Capitalization $4.74 Million USD

Valuation Analysis

Below Book Valuation: The market values IBKS No3 SPAC's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: IBKS No3 SPAC's assets decreased by 3.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for IBKS No3 SPAC (2015–2024)

The table below shows the annual total assets of IBKS No3 SPAC from 2015 to 2024.

Year Total Assets Change
2024-12-31 ₩48.97 Billion -3.13%
2023-12-31 ₩50.56 Billion -1.42%
2022-12-31 ₩51.28 Billion -2.65%
2021-12-31 ₩52.68 Billion +4.85%
2020-12-31 ₩50.24 Billion +16.45%
2019-12-31 ₩43.14 Billion +31.79%
2018-12-31 ₩32.74 Billion +228.46%
2017-12-31 ₩9.97 Billion +0.49%
2016-12-31 ₩9.92 Billion +0.42%
2015-12-31 ₩9.88 Billion --